Computed Tomography (CT) Reconstruction for Axillary Lymph Node Structure
NCT03247478 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 160
Last updated 2019-09-06
Summary
This is a prospective, single-center, non-randomized, non-controlled observational study.
Conditions
Sponsors & Collaborators
-
Peking University
lead OTHER
Principal Investigators
-
Li-ze Wang, MD · Peking University Cancer Hospital & Institute
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-08-25
- Primary Completion
- 2019-06-19
- Completion
- 2019-08-30
Countries
- China
Study Locations
More Related Trials
-
Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in ER-positive Breast Cancer
NCT06695039 ·Status: COMPLETED ·Phase: PHASE2
-
Study on the Value of Non-invasive Dual-Pet Information in Subtype of Metastatic Breast Cancer
NCT04758416 ·Status: UNKNOWN
-
CT and MRI in Prediction of Response in Patients With Gastric Cancer Following Neoadjuvant Chemotherapy and/or Immunotherapy
NCT04913896 ·Status: UNKNOWN
-
Axillary Surgery De-escalation After Neoadjuvant Therapy Using Dedicate Breast PET
NCT05914402 ·Status: RECRUITING ·Phase: NA
-
Monitoring Response to Neoadjuvant Chemotherapy in Breast Cancer Using Ultrafast DCE-MRI
NCT05744518 ·Status: UNKNOWN
-
Influence of PET/CT Radiomic Features on the Outcome of Lung Cancer Patients
NCT03648151 ·Status: COMPLETED
-
Imaging of Primary or Recurrent Breast Cancer With 18F-FluorThanatrace PET/CT
NCT03846167 ·Status: ACTIVE_NOT_RECRUITING
-
Positron Nuclide Labeled NOTA-FAPI PET Study in Lymphoma
NCT04367948 ·Status: UNKNOWN ·Phase: NA
-
An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation
NCT01260480 ·Status: UNKNOWN ·Phase: PHASE2
-
PET and MRI in the Follow-up of Neoadjuvant Chemotherapy of Breast Cancer
NCT00236275 ·Status: COMPLETED ·Phase: PHASE3
-
Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in Invasive Lobular Carcinoma
NCT05960201 ·Status: COMPLETED ·Phase: PHASE2
-
Positron Emission Tomography Using 3'-Deoxy-3'-(18F) Fluorothymidine in Treating Women With Locally Advanced Cancer in One Breast Who Are Receiving Chemotherapy
NCT00534274 ·Status: COMPLETED ·Phase: NA
-
Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Peripheral T-cell Lymphoma
NCT03051568 ·Status: UNKNOWN ·Phase: NA
-
CtDNA After Chemotherapy in Elderly Patients With Acute Leukemia
NCT04157569 ·Status: RECRUITING
-
Phase II Study of Fluorine-18 3'-Deoxy-3'-Fluorothymidine (F-18-FLT) in Invasive Breast Cancer
NCT00572728 ·Status: COMPLETED ·Phase: PHASE2
-
Al18F-HER2-BCH PET in Breast Patients Treated With ADC Therapy
NCT06909604 ·Status: RECRUITING ·Phase: NA
-
The Prognostic Value of FDG PET/CT and Diffusion-weighed Imaging on Breast Cancer
NCT01942759 ·Status: COMPLETED
-
Rectal Cancer: Local Staging, Re-staging and Assessment of Lymph Nodes Using Pet-Ct, CT-Perfusion and 3T MRI
NCT01525056 ·Status: COMPLETED ·Phase: PHASE2
-
68Ga-NOTA Evans Blue PET/CT in Patients With Lymphatic System Related Diseases
NCT05140083 ·Status: UNKNOWN ·Phase: PHASE1
-
Neoadjuvant Chemotherapy Response Assessment by Combined PET-MRI in Borderline and Locally Advanced Pancreatic Adenocarcinoma.
NCT03202199 ·Status: UNKNOWN ·Phase: NA
-
18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Peripheral T-cell Lymphoma
NCT03051581 ·Status: UNKNOWN ·Phase: NA
-
Application of 68Ga NEB PET Imaging in the Diagnosis and Evaluation of Lymphatic Disorders
NCT04273334 ·Status: UNKNOWN ·Phase: PHASE1
-
Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Natural Killer/T-cell Lymphoma
NCT03051542 ·Status: UNKNOWN ·Phase: NA
-
PET Scans and CT Scans in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy
NCT00388024 ·Status: COMPLETED
-
An Imaging Study in ER Negative Breast Cancer by Targeting αvβ6
NCT06978478 ·Status: WITHDRAWN ·Phase: NA